A 10-year-old boy with juvenile myoclonic epilepsy has been well-controlled on sodium valproate for 18 months. He presents with a 3-week history of a tremor affecting both hands, which is interfering with his schoolwork. His parents are concerned. Examination reveals a fine postural tremor but no other neurological signs. Sodium valproate level is within therapeutic range. What is the most appropriate management?
Q102
A 7-year-old girl with type 1 diabetes for 2 years is admitted with her second episode of diabetic ketoacidosis in 6 months. Both episodes occurred when she was unwell with intercurrent infections. Her parents appear knowledgeable about diabetes management and the child is usually compliant. During admission, blood tests reveal: pH 7.18, bicarbonate 11 mmol/L, blood glucose 24.3 mmol/L, and ketones 4.8 mmol/L. What additional investigation would be most important to guide future management?
Q103
A 14-year-old boy with refractory epilepsy presents to clinic. He has failed to achieve adequate seizure control despite trials of three appropriate anti-epileptic medications at therapeutic doses, including sodium valproate, levetiracetam, and lamotrigine. His seizures consist of focal episodes with impaired awareness, sometimes progressing to bilateral tonic-clonic seizures. MRI brain shows a discrete area of cortical dysplasia in the right temporal lobe. What is the most appropriate next step in management?
Q104
A 5-year-old girl with type 1 diabetes is brought to the GP surgery by her mother who is concerned about repeated episodes of unusual behaviour in the mornings before breakfast. The child becomes pale, sweaty, and irritable, and on one occasion had a brief period of confusion. The mother checks blood glucose during an episode and finds it to be 2.2 mmol/L. She is currently on twice-daily mixed insulin. What is the most appropriate adjustment to her insulin regimen?
Q105
What is the first-line anti-epileptic drug recommended by NICE for newly diagnosed generalized tonic-clonic seizures in children aged 12 years and above?
Q106
A 12-year-old boy with type 1 diabetes for 4 years attends clinic. His HbA1c has been consistently 55-60 mmol/mol (7.2-7.6%) over the past 2 years. He is on a basal-bolus insulin regimen. Annual screening reveals microalbuminuria with an albumin:creatinine ratio of 4.5 mg/mmol on two separate occasions. Blood pressure is 118/72 mmHg (90th centile). What is the most appropriate initial management?
Q107
A 9-year-old girl with epilepsy has been taking phenytoin for focal seizures with impaired awareness. She presents to clinic for routine review. Her mother reports that her seizures are well-controlled but she has noticed coarsening of her daughter's facial features and excessive gum growth. Blood tests show therapeutic phenytoin levels. Which medication change would be most appropriate to address these adverse effects while maintaining seizure control?
Q108
A 16-year-old boy with drug-resistant focal epilepsy undergoes video-EEG telemetry to characterize his seizures before possible epilepsy surgery. The recordings show that his seizures consistently originate from the left temporal lobe, and neuropsychological testing confirms left hemisphere language dominance. MRI reveals left mesial temporal sclerosis. What is the most significant risk associated with left temporal lobe resection in this patient?
Q109
A 4-year-old boy with newly diagnosed type 1 diabetes is being discharged from hospital. His parents are being educated about sick day management. Which of the following statements about sick day rules is correct?
Q110
A 15-year-old girl with juvenile myoclonic epilepsy is well-controlled on sodium valproate. She is sexually active and requests contraceptive advice. She is counselled about the teratogenic risks of valproate. After discussion, she wishes to continue valproate as she has failed multiple other antiepileptic drugs and had frequent seizures. What is the most appropriate contraceptive management?
Chronic Paediatric Conditions UK Medical PG Practice Questions and MCQs
Question 101: A 10-year-old boy with juvenile myoclonic epilepsy has been well-controlled on sodium valproate for 18 months. He presents with a 3-week history of a tremor affecting both hands, which is interfering with his schoolwork. His parents are concerned. Examination reveals a fine postural tremor but no other neurological signs. Sodium valproate level is within therapeutic range. What is the most appropriate management?
A. Add propranolol to control the tremor
B. Reduce the sodium valproate dose (Correct Answer)
C. Switch to levetiracetam
D. Reassure and continue current medication
E. Add pyridoxine supplementation
Explanation: ***Reduce the sodium valproate dose***
- **Fine postural tremor** is a well-recognized **dose-dependent side effect** of sodium valproate, occurring even when serum levels are within the **therapeutic range**.
- Reducing the dose to the **minimum effective dose** often alleviates the tremor while maintaining seizure control in patients with **juvenile myoclonic epilepsy**.
*Add propranolol to control the tremor*
- While **beta-blockers** like propranolol can treat tremors, it is preferable to manage the **underlying cause** by adjusting the offending medication first.
- Adding another drug increases the risk of **polypharmacy** and side effects in a pediatric patient who is otherwise well-controlled.
*Switch to levetiracetam*
- **Levetiracetam** is an alternative for juvenile myoclonic epilepsy, but switching medications is premature when the patient has been **well-controlled** for 18 months.
- A complete switch carries a risk of **seizure recurrence** or development of new side effects, such as behavioral changes.
*Reassure and continue current medication*
- This approach is inappropriate because the tremor is **interfering with schoolwork** and daily functioning, necessitating medical intervention.
- **Dose-dependent side effects** should be addressed if they negatively impact a patient's **quality of life**.
*Add pyridoxine supplementation*
- **Pyridoxine (Vitamin B6)** supplementation is used for specific metabolic conditions or to mitigate side effects of medications like **isoniazid**, but not for valproate-induced tremors.
- There is no clinical **evidence base** supporting the use of pyridoxine to treat postural tremors caused by sodium valproate.
Question 102: A 7-year-old girl with type 1 diabetes for 2 years is admitted with her second episode of diabetic ketoacidosis in 6 months. Both episodes occurred when she was unwell with intercurrent infections. Her parents appear knowledgeable about diabetes management and the child is usually compliant. During admission, blood tests reveal: pH 7.18, bicarbonate 11 mmol/L, blood glucose 24.3 mmol/L, and ketones 4.8 mmol/L. What additional investigation would be most important to guide future management?
A. Measure C-peptide levels to assess residual beta-cell function
B. Test for anti-GAD antibodies to confirm autoimmune etiology
C. Screen for coeliac disease with tissue transglutaminase antibodies
D. Assess for psychosocial factors and perform home visit assessment (Correct Answer)
E. Check thyroid function tests for associated autoimmune thyroid disease
Explanation: ***Assess for psychosocial factors and perform home visit assessment***- Recurrent **Diabetic Ketoacidosis (DKA)** in a child with established Type 1 DM, despite seemingly knowledgeable parents and child compliance, strongly suggests underlying **psychosocial triggers** or barriers to implementing **sick-day rules**.- A **multidisciplinary assessment** and a **home visit** can uncover practical management challenges, family stress, or psychological factors that are not evident in a clinic setting but contribute to DKA recurrence.*Measure C-peptide levels to assess residual beta-cell function*- By 2 years post-diagnosis, most children with **Type 1 Diabetes** have very low or undetectable **C-peptide** levels, indicating minimal residual beta-cell function. This measurement would not significantly alter management.- Assessing residual insulin production does not address the immediate issue of recurrent DKA triggered by intercurrent infections, which points to a management or psychosocial gap.*Test for anti-GAD antibodies to confirm autoimmune etiology*- The diagnosis of **Type 1 Diabetes** is already established in this patient; therefore, re-testing for **anti-GAD antibodies** (a marker of autoimmune etiology) is not necessary for guiding future management of recurrent DKA.- This test helps confirm the initial diagnosis but provides no insight into the reasons for repeated metabolic decompensation in a child already diagnosed with and managing Type 1 DM.*Screen for coeliac disease with tissue transglutaminase antibodies*- While **Coeliac disease** is a common comorbidity with Type 1 Diabetes and routine screening is recommended, it typically presents with symptoms like malabsorption, growth faltering, or erratic blood glucose control, not recurrent DKA as its primary manifestation.- Screening for coeliac disease is part of comprehensive long-term care, but it is not the most immediate or crucial investigation to prevent further acute DKA episodes in this specific clinical scenario.*Check thyroid function tests for associated autoimmune thyroid disease*- **Autoimmune thyroid disease** (e.g., Hashimoto's thyroiditis) is frequently associated with Type 1 Diabetes (part of Polyglandular Autoimmune Syndrome), but thyroid dysfunction itself does not typically cause recurrent **DKA** during infections.- Like coeliac screening, checking thyroid function tests is important for **long-term surveillance** of comorbidities, but it is not the most important investigation to address the underlying cause of repeated DKA in this context.
Question 103: A 14-year-old boy with refractory epilepsy presents to clinic. He has failed to achieve adequate seizure control despite trials of three appropriate anti-epileptic medications at therapeutic doses, including sodium valproate, levetiracetam, and lamotrigine. His seizures consist of focal episodes with impaired awareness, sometimes progressing to bilateral tonic-clonic seizures. MRI brain shows a discrete area of cortical dysplasia in the right temporal lobe. What is the most appropriate next step in management?
A. Trial of a fourth anti-epileptic drug (topiramate)
B. Referral to a tertiary epilepsy surgery centre for evaluation (Correct Answer)
C. Commence ketogenic diet
D. Add clobazam as adjunctive therapy
E. Increase lamotrigine to supra-therapeutic levels
Explanation: ***Referral to a tertiary epilepsy surgery centre for evaluation***- This patient meets the criteria for **drug-resistant epilepsy**, having failed trials of three appropriate **anti-epileptic drugs (AEDs)**.- The presence of a **discrete structural lesion** (cortical dysplasia in the right temporal lobe) that correlates with the **focal seizure semiology** makes him an ideal candidate for **epilepsy surgery**, which offers the best chance for seizure freedom.*Trial of a fourth anti-epileptic drug (topiramate)*- The likelihood of achieving sustained **seizure freedom** with a fourth or subsequent AED after failing two or more is very low, typically **less than 5%**.- Further medical trials delay definitive treatment, especially when a **surgically remediable lesion** has been identified.*Commence ketogenic diet*- The **ketogenic diet** is an effective non-pharmacological treatment for **refractory epilepsy**, particularly in children, but it is generally considered when surgery is not an option or has failed.- For **lesional focal epilepsy**, **surgical resection** is usually the first-line advanced treatment due to its potential for cure.*Add clobazam as adjunctive therapy*- **Clobazam** is a benzodiazepine often used as an **adjunctive therapy** to reduce seizure frequency, but it is rarely curative for **drug-resistant epilepsy**.- Its use would represent continued **palliative pharmacotherapy** rather than addressing the underlying resectable **epileptogenic focus**.*Increase lamotrigine to supra-therapeutic levels*- Increasing **lamotrigine** to **supra-therapeutic levels** carries a high risk of **adverse effects**, such as rash, dizziness, and ataxia, without a significant increase in efficacy for **drug-resistant epilepsy**.- This approach does not address the underlying **structural cause** of the seizures and is not standard practice.
Question 104: A 5-year-old girl with type 1 diabetes is brought to the GP surgery by her mother who is concerned about repeated episodes of unusual behaviour in the mornings before breakfast. The child becomes pale, sweaty, and irritable, and on one occasion had a brief period of confusion. The mother checks blood glucose during an episode and finds it to be 2.2 mmol/L. She is currently on twice-daily mixed insulin. What is the most appropriate adjustment to her insulin regimen?
A. Increase the morning short-acting insulin dose
B. Reduce the evening long-acting insulin component (Correct Answer)
C. Add a bedtime snack with complex carbohydrates
D. Switch to a basal-bolus regimen with glargine at bedtime
E. Increase the evening short-acting insulin dose
Explanation: ***Reduce the evening long-acting insulin component***- The child's episodes of paleness, sweating, irritability, confusion, and a blood glucose of **2.2 mmol/L** in the mornings before breakfast are classic signs of **nocturnal or fasting hypoglycemia**.- In a twice-daily mixed insulin regimen, the **long-acting component** of the evening dose provides basal insulin coverage overnight. If this component is excessive, it will cause glucose levels to drop too low by morning.*Increase the morning short-acting insulin dose*- Increasing the morning short-acting insulin would primarily affect **post-breakfast blood glucose levels** and would not address the pre-breakfast hypoglycemia.- This action would be inappropriate and potentially dangerous as the child is already experiencing morning hypoglycemia.*Add a bedtime snack with complex carbohydrates*- While a bedtime snack can temporarily mitigate nocturnal hypoglycemia, it is a supportive measure rather than a definitive solution for an **overdosed insulin regimen**.- The primary goal should be to adjust the insulin dose to physiological needs, not to compensate for excess insulin with extra food intake.*Switch to a basal-bolus regimen with glargine at bedtime*- A **basal-bolus regimen** offers greater flexibility and often better control for type 1 diabetes, but it is a major regimen change rather than the most immediate and appropriate adjustment for correcting an existing insulin overdose.- This complex switch would require new dose titration and does not directly solve the current acute problem of excessive evening long-acting insulin.*Increase the evening short-acting insulin dose*- Increasing the **short-acting component** of the evening mixed insulin dose would lower blood glucose primarily in the period **immediately after dinner**.- This would likely cause early nocturnal hypoglycemia and would not resolve or could even worsen the pre-breakfast hypoglycemia observed.
Question 105: What is the first-line anti-epileptic drug recommended by NICE for newly diagnosed generalized tonic-clonic seizures in children aged 12 years and above?
A. Levetiracetam
B. Lamotrigine
C. Carbamazepine
D. Sodium valproate (Correct Answer)
E. Topiramate
Explanation: ***Sodium valproate***
- **Sodium valproate** is the recommended **first-line** treatment by NICE for newly diagnosed **generalized tonic-clonic seizures** due to its broad-spectrum efficacy.
- Although highly effective, it carries significant **teratogenic risks** and potential neurodevelopmental issues, requiring careful consideration in females of childbearing potential.
*Levetiracetam*
- It is typically considered a **second-line** option or an alternative when first-line medications are unsuitable or not tolerated.
- While effective for **generalized seizures**, it is not the initial first-line recommendation for newly diagnosed cases by NICE.
*Lamotrigine*
- Often used as an add-on therapy or second-line for generalized seizures, it can sometimes **exacerbate** certain generalized seizure types, such as myoclonic jerks.
- It requires a slow **titration period** to minimize the risk of serious skin reactions like **Stevens-Johnson syndrome**.
*Carbamazepine*
- This drug is primarily used as **first-line therapy** for **focal seizures**, not for generalized seizures.
- It is contraindicated in generalized epilepsies because it can **exacerbate generalized tonic-clonic**, absence, or myoclonic seizures.
*Topiramate*
- Recommended as an **adjunctive** treatment or a **second-line** option rather than a primary first-line choice for pediatric patients.
- It carries a significant side-effect profile, including **cognitive slowing** and an increased risk of **renal stones**.
Question 106: A 12-year-old boy with type 1 diabetes for 4 years attends clinic. His HbA1c has been consistently 55-60 mmol/mol (7.2-7.6%) over the past 2 years. He is on a basal-bolus insulin regimen. Annual screening reveals microalbuminuria with an albumin:creatinine ratio of 4.5 mg/mmol on two separate occasions. Blood pressure is 118/72 mmHg (90th centile). What is the most appropriate initial management?
A. Start ACE inhibitor therapy
B. Intensify insulin therapy to reduce HbA1c to <48 mmol/mol (Correct Answer)
C. Start low-dose aspirin therapy
D. Refer urgently to paediatric nephrology
E. Review in 12 months with repeat albumin:creatinine ratio
Explanation: ***Intensify insulin therapy to reduce HbA1c to <48 mmol/mol***
- The first-line management for early **diabetic nephropathy** in children is optimizing **glycaemic control**, as improving blood glucose levels can reverse persistent **microalbuminuria**.
- This patient's **HbA1c** (55-60 mmol/mol) exceeds the NICE-recommended target of **<48 mmol/mol** (6.5%), suggesting significant room for improvement in metabolic management.
*Start ACE inhibitor therapy*
- **ACE inhibitors** are typically reserved for patients who have persistent microalbuminuria despite **optimized glycaemic control** or those with frank **hypertension**.
- While his blood pressure is at the **90th centile**, the diagnosis of hypertension requires higher values or repeated elevated readings, making insulin adjustment a more appropriate initial step.
*Start low-dose aspirin therapy*
- There is currently no clinical indication for **low-dose aspirin** in the routine management of **paediatric diabetic nephropathy**.
- Aspirin is generally used for secondary prevention of **cardiovascular disease**, which is not the immediate concern for this 12-year-old child.
*Refer urgently to paediatric nephrology*
- Early-stage microalbuminuria is typically managed within **paediatric diabetes clinics** through lifestyle and medical optimization.
- An **urgent nephrology referral** is premature and only indicated for rapid decline in **GFR**, nephrotic-range proteinuria, or resistant hypertension.
*Review in 12 months with repeat albumin:creatinine ratio*
- Doing nothing for a year is inappropriate given that **persistent microalbuminuria** (confirmed on two occasions) is a marker of early **organ damage**.
- Delaying intervention increases the risk of progression to **macroalbuminuria** and irreversible **chronic kidney disease**.
Question 107: A 9-year-old girl with epilepsy has been taking phenytoin for focal seizures with impaired awareness. She presents to clinic for routine review. Her mother reports that her seizures are well-controlled but she has noticed coarsening of her daughter's facial features and excessive gum growth. Blood tests show therapeutic phenytoin levels. Which medication change would be most appropriate to address these adverse effects while maintaining seizure control?
A. Switch to carbamazepine
B. Switch to lamotrigine (Correct Answer)
C. Add sodium valproate to phenytoin
D. Reduce phenytoin dose by 50%
E. Switch to levetiracetam
Explanation: ***Switch to lamotrigine***
- **Lamotrigine** is an effective anti-epileptic drug for **focal seizures** and is particularly suitable here as it does not cause the **cosmetic side effects** like gingival hyperplasia or facial coarsening seen with phenytoin.
- It offers good **tolerability** and is a preferred choice for long-term management in children, avoiding the fibroblast stimulation responsible for **gum growth**.
*Switch to carbamazepine*
- While effective for **focal seizures**, **carbamazepine** is known for its own set of significant side effects, including a risk of **Stevens-Johnson syndrome** and **hyponatremia**.
- It is also an **enzyme inducer** and may not be the ideal choice to switch to when the primary goal is to improve cosmetic side effects without introducing new significant risks.
*Add sodium valproate to phenytoin*
- This approach would involve **polytherapy**, increasing the risk of **drug-drug interactions** and potential side effects from sodium valproate itself, such as **weight gain** or **hepatic dysfunction**.
- It does not directly address the **phenytoin-induced adverse effects** (gingival hyperplasia, facial coarsening) which are the main concern.
*Reduce phenytoin dose by 50%*
- Reducing the phenytoin dose significantly would likely lead to **subtherapeutic levels**, resulting in a **loss of seizure control** which is unacceptable given the seizures are currently well-controlled.
- The cosmetic side effects like **gingival hypertrophy** are often dose-independent and require a change of medication rather than just a dose reduction, especially when levels are already therapeutic.
*Switch to levetiracetam*
- **Levetiracetam** is an effective broad-spectrum anti-epileptic drug for focal seizures and does not cause cosmetic side effects.
- However, it is frequently associated with **behavioral side effects** like **irritability**, **aggression**, and **mood changes** in children, which might be a concern in a 9-year-old girl.
Question 108: A 16-year-old boy with drug-resistant focal epilepsy undergoes video-EEG telemetry to characterize his seizures before possible epilepsy surgery. The recordings show that his seizures consistently originate from the left temporal lobe, and neuropsychological testing confirms left hemisphere language dominance. MRI reveals left mesial temporal sclerosis. What is the most significant risk associated with left temporal lobe resection in this patient?
A. Contralateral hemiparesis
B. Visual field defect
C. Verbal memory impairment (Correct Answer)
D. Non-verbal memory impairment
E. Personality change
Explanation: ***Verbal memory impairment***- In patients with **left hemisphere language dominance**, the **left temporal lobe**, specifically the **hippocampus**, is critical for **verbal memory** processing.- Resection of the **dominant mesial temporal lobe** carries a high risk of postoperative decline in the ability to learn and recall new verbal information, making it the most significant risk in this context.*Contralateral hemiparesis*- This complication arises from damage to the **primary motor cortex** or the **corticospinal tract**, which are located in the frontal lobe and brainstem, areas generally preserved during a temporal lobe resection.- Standard **temporal lobe surgery** focuses on anterior and mesial structures, positioned distant from the **motor pathways**.*Visual field defect*- While a **superior quadrantanopia** (pie-in-the-sky defect) can occur due to injury to **Meyer's loop** (optic radiation) in the temporal lobe, it is often less functionally debilitating than severe memory loss.- Though a known surgical risk, it is usually not considered the *most significant* long-term neuropsychological consequence compared to language-related memory deficits in the dominant hemisphere.*Non-verbal memory impairment*- **Non-verbal memory**, such as visuospatial and facial recognition, is predominantly mediated by the **non-dominant (typically right)** temporal lobe.- Since this patient has **left hemisphere language dominance** and **left temporal lobe pathology**, the risk of **non-verbal memory impairment** is substantially lower than that for verbal memory.*Personality change*- Significant shifts in **personality**, social conduct, and executive functions are more commonly linked to damage or resection of the **frontal lobes**.- While temporal lobe epilepsy can have associated behavioral changes, direct surgical removal of the **mesial temporal lobe** itself typically does not result in global personality alterations.
Question 109: A 4-year-old boy with newly diagnosed type 1 diabetes is being discharged from hospital. His parents are being educated about sick day management. Which of the following statements about sick day rules is correct?
A. Insulin doses should be reduced by 50% during illness to prevent hypoglycaemia
B. Insulin should never be stopped, even if the child is not eating (Correct Answer)
C. Blood glucose monitoring can be reduced to twice daily during illness
D. Ketone testing is only necessary if blood glucose exceeds 20 mmol/L
E. Carbohydrate intake should be restricted to prevent hyperglycaemia
Explanation: ***Insulin should never be stopped, even if the child is not eating***
- During illness, **stress hormones** like cortisol and adrenaline increase **insulin resistance** and glucose production, necessitating continuous insulin therapy.
- Stopping insulin is a primary trigger for **diabetic ketoacidosis (DKA)**, as the body requires at least basal insulin to suppress lipolysis.
*Insulin doses should be reduced by 50% during illness to prevent hypoglycaemia*
- Reducing insulin arbitrarily is dangerous because illness typically increases **metabolic demands** and hyperglycemic risk.
- While mealtime insulin might be adjusted based on intake, **basal insulin** usually needs to be maintained or even increased to prevent ketosis.
*Blood glucose monitoring can be reduced to twice daily during illness*
- Monitoring frequency should be **increased** to every 2–4 hours (or more frequently) during sick days to track rapid changes in glucose levels.
- Frequent checks allow for timely **correction boluses** and help identify the early onset of dehydration or DKA.
*Ketone testing is only necessary if blood glucose exceeds 20 mmol/L*
- Current guidelines recommend checking for **ketones** if the child is unwell or if blood glucose levels rise above **14 mmol/L**.
- Ketones indicate how much fat is being metabolized for energy, acting as an early warning sign of impending **ketoacidosis** regardless of the specific glucose level.
*Carbohydrate intake should be restricted to prevent hyperglycaemia*
- Adequate **carbohydrate intake** must be maintained (using clear fluids or sugary drinks if solids aren't tolerated) to provide energy and prevent starvation ketosis.
- Restricting carbohydrates while the body is under stress can lead to **hypoglycemia** or further promote ketone production.
Question 110: A 15-year-old girl with juvenile myoclonic epilepsy is well-controlled on sodium valproate. She is sexually active and requests contraceptive advice. She is counselled about the teratogenic risks of valproate. After discussion, she wishes to continue valproate as she has failed multiple other antiepileptic drugs and had frequent seizures. What is the most appropriate contraceptive management?
A. Combined oral contraceptive pill as first-line choice
B. Progesterone-only pill due to enzyme induction concerns
C. Copper intrauterine device (IUD) as most reliable option (Correct Answer)
D. Contraceptive implant with additional barrier methods
E. Depot medroxyprogesterone acetate injection (DMPA)
Explanation: ***Copper intrauterine device (IUD) as most reliable option***
- The **copper IUD** is a **long-acting reversible contraceptive (LARC)** with a failure rate of <1%, making it the most reliable choice to prevent pregnancy while on highly **teratogenic sodium valproate**.
- Unlike hormonal methods, it has no metabolic interactions with **antiepileptic drugs** and avoids any potential (though small) risks of hormonal influence on seizure thresholds.
*Combined oral contraceptive pill as first-line choice*
- The **combined oral contraceptive pill (COCP)** has a higher typical-use failure rate due to **compliance issues**, which is unacceptable given the risk of **fetal valproate syndrome**.
- Although sodium valproate is not an **enzyme-inducer**, the risk of user error makes the COCP an inferior choice compared to LARCs in this high-risk scenario.
*Progesterone-only pill due to enzyme induction concerns*
- The **progesterone-only pill (POP)** requires strict daily adherence, and its high **failure rate** makes it unsuitable for patients needing to avoid pregnancy for medical/safety reasons.
- The premise of the option is incorrect as **sodium valproate is not an enzyme-inducing drug**, unlike phenytoin or carbamazepine.
*Contraceptive implant with additional barrier methods*
- While the **progestogen implant** is a LARC, it is generally considered less preferred than the IUD in some guidelines when maximal reliability is required for **teratogenic drug** users.
- Relying on **barrier methods** as a primary addition is poor practice compared to selecting a single method with the highest baseline efficacy like an **intrauterine device**.
*Depot medroxyprogesterone acetate injection (DMPA)*
- **DMPA injections** are effective but carry concerns regarding a reversible reduction in **bone mineral density**, which is a significant consideration in a **15-year-old** adolescent.
- It requires repeated visits every 12-13 weeks, which introduces a higher risk of **missed doses** compared to the "set and forget" nature of the **Copper IUD**.
